SCHEMBL11729681

SCHEMBL11729681

O=c1c(Cl)c(NN2CCOCC2)cnn1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 1/20 0.48
▸ MCHR1 Q99705 1/20 0.48
▸ KMT2A Q03164 4/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ CTSK P43235 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ RAB9A P51151 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norflurazone SCHEMBL54676 0.80 CYP1A2 (0.66) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
Norflurazone SCHEMBL6512279 0.80 CYP1A2 (0.66) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
Norflurazone SCHEMBL29776940 0.80 CYP1A2 (0.66) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
SCHEMBL11727557 0.80 NPBWR1 (0.53) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
Norflurazone SCHEMBL7039956 0.79 CYP1A2 (0.64) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
Norflurazone SCHEMBL28530944 0.79 CYP1A2 (0.64) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
SCHEMBL3037242 0.76 NPC1 (0.64) NPBWR1MCHR1KMT2ASMN1; SMN2CTSK
SCHEMBL11736103 0.76 NPBWR1 (0.48) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
Norflurazone SCHEMBL28173162 0.75 CYP1A2 (0.61) NPBWR1MCHR1KMT2ASMN1; SMN2PKM
Norflurazone SCHEMBL27382340 0.75 CYP1A2 (0.61) NPBWR1MCHR1KMT2ASMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4002751-A SLEEP INDUCERS, CNS DEPRESSANTS SANDOZ, INC. (US) 1977-01-11 — — US disclosed
Send feedback